As Scientific Director, Farhad Islami, MD, PhD, leads the Cancer Disparity Research team in the Data Science research group at the American Cancer Society (ACS). He primarily conducts transdisciplinary research to identify individual, social, biological, structural, and system level determinants of health and to estimate the contribution of each to cancer disparities. The objective of this work is to inform cancer care delivery and public policy. He also conducts and collaborates on research focused on cancer surveillance and risk factors.
Areas of Interest
- Cancer Prevention
- Health Disparities
Affiliations & Activities
Islami’s research focuses on quantifying the impact of factors that contribute to cancer disparities across the cancer continuum. He has also conducted extensive research on the risk factors of cancer that are potentially modifiable.
As a member of the International Agency for Research on Cancer (IARC) team, Islami has been in multiple IARC Monographs and Handbooks and an IARC Monograph Working Group Member for Monograph volume 116, Carcinogenicity of Drinking Coffee, Mate, and Very Hot Beverages.
Full publication list:
- Islami F, Siegel RL, Jemal A, 2020, The changing landscape of cancer in the USA — Opportunities for advancing prevention and treatment, Nature Reviews Clinical Oncology, 17, 631-649
- Islami F, Miller KD, Siegel RL, Zheng Z, Zhao J, Han X, Ma J, Jemal A, Yabroff KR, 2019, National and state estimates of lost earnings from cancer deaths in the United States, JAMA Oncology, 5, e191460
- Islami F, Goding Sauer A, Gapstur SM, Jemal A, 2019, Proportion of cancer cases attributable to excess body weight by US state, 2011-2015, JAMA Oncology, 5, 384-392
- Islami F, Fedewa SA, Jemal A, 2019, Trends in cervical cancer incidence rates by age, race/ethnicity, histological subtype, and stage at diagnosis in the United States, Preventive Medicine, 123, 316-323
- Islami F, DeSantis CE, Jemal A, 2018, Incidence trends of esophageal and gastric cancer subtypes by race, ethnicity, and age in the United States, 1997-2014, Clinical Gastroenterology & Hepatology, 17, 429-439
- Islami F, Goding Sauer A, Miller KD, Siegel RL, Fedewa SA, Jacobs EJ, McCullough ML, Patel AV, Ma J, Soerjomataram I, Flanders WD, Brawley OW, Gapstur SM, Jemal A, 2018, Proportion and number of cancer cases and deaths attributable to potentially modifiable risk factors in the United States, CA—A Cancer Journal for Clinicians, 68, 31-54